Outset Historical Financial Ratios
| OM Stock | USD 0.73 0.03 3.91% |
Outset Medical is promptly reporting on over 98 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Stock Based Compensation To Revenue of 0.29, Capex To Depreciation of 0.65 or Pb Ratio of 2.06 will help investors to properly organize and evaluate Outset Medical financial condition quickly.
Outset |
About Outset Financial Ratios Analysis
Outset MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Outset Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Outset financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Outset Medical history.
Outset Medical Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Outset Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Outset Medical sales, a figure that is much harder to manipulate than other Outset Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from Outset Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Outset Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.At this time, Outset Medical's Debt To Equity is very stable compared to the past year. As of the 27th of February 2025, Capex Per Share is likely to grow to 0.09, though Free Cash Flow Yield is likely to grow to (1.92).
| 2022 | 2023 | 2024 | 2025 (projected) | Receivables Turnover | 4.11 | 3.95 | 3.56 | 3.4 | Current Ratio | 7.19 | 5.26 | 6.05 | 8.7 |
Outset Medical fundamentals Correlations
Click cells to compare fundamentals
Outset Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Outset Medical fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 48.63 | 20.48 | 10.78 | 2.06 | 0.51 | 0.48 | |
| Ptb Ratio | 7.39 | 5.62 | 5.06 | 2.18 | 1.96 | 2.06 | |
| Free Cash Flow Yield | (0.0445) | (0.0635) | (0.12) | (0.5) | (2.02) | (1.92) | |
| Operating Cash Flow Per Share | (2.32) | (2.86) | (3.03) | (2.65) | (2.24) | (2.35) | |
| Stock Based Compensation To Revenue | 0.43 | 0.17 | 0.24 | 0.3 | 0.34 | 0.29 | |
| Capex To Depreciation | 2.88 | 0.6 | 1.61 | 0.59 | 0.68 | 0.65 | |
| Pb Ratio | 7.39 | 5.62 | 5.06 | 2.18 | 1.96 | 2.06 | |
| Free Cash Flow Per Share | (2.53) | (2.93) | (3.2) | (2.72) | (2.24) | (2.35) | |
| Inventory Turnover | 3.43 | 2.42 | 1.89 | 2.06 | 2.37 | 3.6 | |
| Net Income Per Share | (2.83) | (2.89) | (3.38) | (3.48) | (2.46) | (2.59) | |
| Payables Turnover | 12.73 | 53.88 | 161.76 | 17.4 | 15.66 | 14.87 | |
| Research And Ddevelopement To Revenue | 0.58 | 0.36 | 0.42 | 0.44 | 0.34 | 0.32 | |
| Capex To Revenue | 0.22 | 0.18 | 0.0303 | 0.0722 | 0.0264 | 0.0288 | |
| Pocfratio | (24.52) | (16.13) | (8.53) | (2.04) | (0.5) | (0.52) | |
| Interest Coverage | (49.67) | (76.1) | (45.15) | (13.39) | 4.75 | 4.99 | |
| Capex To Operating Cash Flow | (0.092) | (0.0239) | (0.0571) | (0.0262) | (0.0236) | (0.0247) | |
| Pfcf Ratio | (22.46) | (15.75) | (8.07) | (1.99) | (0.5) | (0.52) | |
| Income Quality | 1.03 | 0.81 | 0.99 | 0.89 | 0.76 | 0.87 | |
| Roe | (0.37) | (0.35) | (0.66) | (1.41) | (1.62) | (1.54) | |
| Pe Ratio | (20.12) | (15.93) | (7.63) | (1.55) | (0.45) | (0.47) | |
| Return On Tangible Assets | (0.3) | (0.28) | (0.41) | (0.55) | (0.5) | (0.52) | |
| Earnings Yield | (0.0497) | (0.0628) | (0.13) | (0.64) | (2.22) | (2.11) | |
| Current Ratio | 9.43 | 7.93 | 7.19 | 5.26 | 6.05 | 8.7 | |
| Receivables Turnover | 7.72 | 4.01 | 4.11 | 3.95 | 3.56 | 3.4 | |
| Debt To Equity | 0.12 | 0.1 | 0.42 | 1.11 | 1.0 | 1.05 | |
| Capex Per Share | 0.21 | 0.0682 | 0.17 | 0.0694 | 0.0624 | 0.088 | |
| Revenue Per Share | 1.17 | 2.25 | 2.4 | 2.63 | 2.19 | 1.26 | |
| Debt To Assets | 0.0956 | 0.0816 | 0.26 | 0.43 | 0.39 | 0.41 | |
| Days Sales Outstanding | 47.28 | 91.07 | 88.8 | 92.33 | 106.18 | 112.22 | |
| Book Value Per Share | 7.69 | 8.21 | 5.11 | 2.48 | 2.23 | 2.34 | |
| Ev To Sales | 43.5 | 19.07 | 11.04 | 2.58 | 2.96 | 2.82 | |
| Days Of Inventory On Hand | 106.56 | 150.56 | 192.62 | 177.2 | 159.48 | 108.5 | |
| Cash Per Share | 7.37 | 7.45 | 5.97 | 4.1 | 3.69 | 4.17 | |
| Days Payables Outstanding | 28.68 | 6.77 | 2.26 | 20.98 | 24.13 | 22.92 | |
| Ev To Operating Cash Flow | (21.94) | (15.02) | (8.74) | (2.56) | (2.3) | (2.42) | |
| Ev To Free Cash Flow | (20.09) | (14.67) | (8.27) | (2.49) | (2.24) | (2.35) | |
| Net Debt To E B I T D A | 2.23 | 1.16 | (0.2) | (0.44) | (0.51) | (0.48) | |
| Tangible Book Value Per Share | 7.69 | 8.21 | 5.11 | 2.48 | 2.23 | 2.34 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Outset Medical. If investors know Outset will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Outset Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Outset Medical is measured differently than its book value, which is the value of Outset that is recorded on the company's balance sheet. Investors also form their own opinion of Outset Medical's value that differs from its market value or its book value, called intrinsic value, which is Outset Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Outset Medical's market value can be influenced by many factors that don't directly affect Outset Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Outset Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Outset Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.